Profil
Derzeit bekleidet Michael E. Kamarck die Position des Chief Technology Officer bei Vir Biotechnology, Inc. Dr. Kamarck ist außerdem Mitglied des Vorstands von Trillium Therapeutics, Inc. und Unilife Medical Solutions, Inc. sowie Mitglied von TransForm Pharmaceuticals, Inc. In der Vergangenheit war er SVP-Global Vaccines & Biologics Manufacturing bei Merck & Co., Inc. und Präsident von Merck BioVentures (einer Tochtergesellschaft von Merck & Co., Inc.), Head-Therapeutic Monoclonal Antibodies bei Sanofi, President-Technical Operations & Product Supply bei Wyeth Pharmaceuticals, Inc. und Principal bei Willow Creek Biotech Consulting LLC. Er erwarb einen Bachelor-Abschluss am Oberlin College und einen Doktortitel am Massachusetts Institute of Technology.
Ehemalige bekannte Positionen von Michael Kamarck
| Unternehmen | Position | Ende |
|---|---|---|
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 30.06.2023 |
| VAXCYTE, INC. | Direktor/Vorstandsmitglied | 30.06.2023 |
| PASSAGE BIO, INC. | Direktor/Vorstandsmitglied | 30.06.2023 |
| TRILLIUM THERAPEUTICS | Direktor/Vorstandsmitglied | 17.11.2021 |
| UNILIFE CORPORATION | Direktor/Vorstandsmitglied | 26.10.2017 |
Ausbildung von Michael Kamarck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Unilife Corp.
Unilife Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets syringes & other medical devices | Health Technology |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Unilife Medical Solutions, Inc.
Unilife Medical Solutions, Inc. Medical SpecialtiesHealth Technology Manufactures medical and surgical devices | Health Technology |
Omni Bio Pharmaceutical, Inc.
Omni Bio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures products for the treatment of immune-mediated inflammatory diseases | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Merck BioVentures | |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Willow Creek Biotech Consulting LLC |
















